The effect of valproate on bone mineral density in adult epileptic patients

Pharmacological Research

Volumn 50, Issue 1, 2004, Pages 93-97

  Boluk, Ayhan ^a   Guzelipek, Mehmet ^a   Savli, Haluk ^a   Temel, Ismail ^a   Ozişik, Handan Işin ^a   Kaygusuz, Akif ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

Bone density; Densitometry; Valproic acid; X ray

Indexed keywords

ALKALINE PHOSPHATASE; ANTICONVULSIVE AGENT; PARATHYROID HORMONE; PHOSPHORUS; VALPROIC ACID;

ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; EPILEPSY; FEMALE; FEMUR; HORMONE DETERMINATION; HUMAN; INTERMETHOD COMPARISON; LONG TERM CARE; LUMBAR VERTEBRA; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MONOTHERAPY; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; ANTICONVULSANTS; BODY MASS INDEX; BONE DENSITY; DENSITOMETRY, X-RAY; EPILEPSY; FEMALE; HUMANS; LIFE STYLE; LOGISTIC MODELS; MALE; RISK FACTORS; VALPROIC ACID;

EID: 1842786823     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phrs.2003.11.011     Document Type: Article

References (14)

1. Pack A.M., Morrell M.J. Adverse effects of antiepileptic drugs on bone structure: epidemiology, mechanisms and therapeutic implications. CNS Drugs. 8:2001;633-642.
2. Sheth R.D. Bone health in epilepsy. Epilepsia. 43:2002;1453-1454.
3. Guo C., Gabriel M., Stephenia A. Long-term valproate and lamotrijine treatment may be marker for reduced growth and bone mass in children with epilepsy. Epilepsia. 42:2001;1141-1147.
4. Farhat G., Yamout B., Mikati M.A., Demirjian R., El Hajj Fuleihan G. Effect of antiepileptic drugs of bone density in ambulatory patients. Neurology. 58:2002;1348-1353.
5. Heller A.J., Chestermen P., Elwes R.D.C., Crawford P., Chadwick D., Johnson A.L.et al. Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomized comparative monotheraphy trial. J. Neurol. Nurosurg. Pschiatry. 58:1995;44-50.
6. Sheth R.D., Wesolowski C.A., Jacob J.C., Penney S., Hobbs G.R., Riggs J.E.et al. Effect of carbamazepine and valproate one bone mineral density. J. Pediatr. 27:1995;256-262.
7. Gillis P., Alliet P., Bruneel E., Raes M. Effect of valproate on bone mineral density (letter). J. Pediatr. 128:1996;441.
8. Kafali G., Erselcan T., Tanzer F. Effect of antiepileptic drugs on bone mineral density between ages 6 and 12 years. Clin. Pediatr. 38:1999;93-99.
9. Akin R., Okutan V., Sarýcý U., Altunbas A., Gokcay E. Evaluation of bone mineral density in children receiving antiepileptic drugs. Pediatr. Neurol. 19:1998;129-131.
10. Jergas M, Genant H. Quantitative bone mineral analysis. In: Resnick D, editor. Diagnosis of bone and joint disorder. 4th ed. Philadelphia: WB Saunders; 2002. p. 1861-96.
11. Kanis J.A., Devogelaer J.P., Gennars C. Practical guide for the use of bone mineral measurements in the assessment of treatment of osteoporosis. A position paper of the European foundation for osteoporosis and bone disease. The Scientific Advisory Board and Board of National Societies. Osteoporos Int. 6:1996;256.
12. Dilşen G., Göksoy T., Barden H.S., Selim N., İşseve H. Bone mineral density values in healthy Turkish population. J. Actual Med. 6:2001;96-108.
13. Sato Y., Kondo I., Ishida S., Motooka H., Takayama K., Tomita Y.et al. Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology. 57:2001;445-449.
14. Weinstein R.S., Byrce G.F., Sappinngton L.J., King D.W., Gallagher B.B. Decreased serum ionized calcium and normal vitamine D metabolite levels with anticonvulsant drug treatment. J. Clin Endocrinol. Metab. 58:1984;1003-1009.